SCHEMBL14679986

SCHEMBL14679986

Cc1ccc(C=C2C(=O)Nc3cc(C)ccc32)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 5/20 0.57
PIM1 P11309 1/20 0.53
MAPT P10636 3/20 0.53
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
ALDH1A1 P00352 2/20 0.51
APP P05067 2/20 0.51
MAPK1 P28482 2/20 0.51
SNCA P37840 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
CTRC Q99895 2/20 0.51
RET P07949 2/20 0.51
FLT3 P36888 1/20 0.51
PLK4 O00444 1/20 0.51
PLK1 P53350 1/20 0.51
KDR P35968 1/20 0.51
NPC1 O15118 1/20 0.51
GMNN O75496 1/20 0.51
LMNA P02545 1/20 0.51
HPGD P15428 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14679936 0.91 PDGFRB (0.66) PDGFRBPIM1KDR
SCHEMBL14679949 0.91 LRRK2 (0.57) PDGFRBPIM1MAPTMEN1KMT2A
SCHEMBL249620 0.88 LRRK2 (0.59) PDGFRB
SCHEMBL249621 0.88 LRRK2 (0.59) PDGFRB
SCHEMBL14679926 0.88 PDGFRB (0.74) PDGFRBPIM1MAPTMEN1KMT2A
SCHEMBL5481961 0.84 PDGFRB (0.72) PDGFRBPIM1MAPTMEN1KMT2A
SCHEMBL5481962 0.84 PDGFRB (0.72) PDGFRBPIM1MAPTMEN1KMT2A
SCHEMBL14679991 0.83 PDGFRB (0.53) PDGFRBMAPTMEN1KMT2AAPP
SCHEMBL14679966 0.82 PDGFRB (0.55) PDGFRBPIM1MEN1KMT2ARET
SCHEMBL10151557 0.81 MEN1 (0.47) PDGFRBMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8877946-B2 Benzylidene-indolinone compounds and their medical use NATIONAL UNIVERSITY OF SINGAPORE (SG) 2014-11-04 US disclosed
US-20130035364-A1 BENZYLIDENE-INDOLINONE COMPOUNDS AND THEIR MEDICAL USE NATIONAL UNIVERSITY OF SINGAPORE (SG) 2013-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130035364-A1 BENZYLIDENE-INDOLINONE COMPOUNDS AND THEIR MEDICAL USE ERBB2, ABL1, IGF1R PDGFRB 11/4885PIM1 647/4885MAPT 2978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.